HIGHLIGHTS
- who: Richard C. Kevin from the Johns Hopkins University, United States have published the research: Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11, in the Journal: (JOURNAL)
- how: It should be noted however that this study was conducted in a different cell type (AtT20 vs. PathHunter CHO cells) and that the authors only used a single marker of membrane integrity disruption. While the authors investigated the widest range of GPCRs in any SCRA study to date other receptor classes like ion_channels remain to be . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.